Maryland Heights, MO, United States of America

Mary Marmion Dyszlewski

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: Mallinckrodt Medical, Inc., Mallinckrodt, Inc.. Active years: 1992-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Marmion Dyszlewski. Retrieved from https://idiyas.com/inventor/mary-marmion-dyszlewski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 87.5

 


Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 102(Granted Patents)


Location History:

  • Maryland Heights, MO (US) (1992 - 2002)
  • Creve Coeur, MO (US) (2005)

Company Filing History:


Years Active: 1992-2005

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Mary Marmion Dyszlewski: Innovator in Radiopharmaceuticals

Introduction

Mary Marmion Dyszlewski is a prominent inventor based in Maryland Heights, MO (US). She has made significant contributions to the field of radiopharmaceuticals, holding a total of seven patents. Her work focuses on the stabilization of radiopharmaceutical preparations and the development of innovative peptide compositions for targeted therapies.

Latest Patents

Among her latest patents, one notable invention is the "Stabilized Radiopharmaceutical Kits." This invention addresses the stabilization of radiopharmaceutical preparations by incorporating cyclic oligosaccharides, such as modified or unmodified cyclodextrins, into the kits. Another significant patent is for "Radiolabeled Peptide Compositions for Site-Specific Targeting." This invention involves radiolabeled peptides designed for diagnostic or therapeutic use, characterized by their unmodified carboxy terminal amino acid. These compositions are particularly useful for targeting specific biological sites, enhancing the efficacy of radiopharmaceutical applications.

Career Highlights

Mary Marmion Dyszlewski has established herself as a key figure in her field through her innovative work at Mallinckrodt Medical, Inc. Her contributions have advanced the development of radiopharmaceuticals, making them more effective and reliable for medical applications.

Collaborations

Throughout her career, Mary has collaborated with notable professionals, including Edward A Deutsch and Mark A DeRosch. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mary Marmion Dyszlewski's work in the field of radiopharmaceuticals exemplifies her dedication to innovation and improvement in medical technology. Her patents reflect her commitment to advancing healthcare solutions through scientific research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…